{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:15:26Z","timestamp":1794946526217,"version":"4.9.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB21\/13\/00055"],"award-info":[{"award-number":["CB21\/13\/00055"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR21\/00026"],"award-info":[{"award-number":["JR21\/00026"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM23\/00095"],"award-info":[{"award-number":["CM23\/00095"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR23\/00036"],"award-info":[{"award-number":["JR23\/00036"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI23\/00074"],"award-info":[{"award-number":["FI23\/00074"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00686"],"award-info":[{"award-number":["PI20\/00686"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/01212"],"award-info":[{"award-number":["PI22\/01212"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/00704"],"award-info":[{"award-number":["PI21\/00704"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/01212"],"award-info":[{"award-number":["PI20\/01212"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/00851"],"award-info":[{"award-number":["PI23\/00851"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","award":["IN607D 2021\/12"],"award-info":[{"award-number":["IN607D 2021\/12"]}],"id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","award":["IN606B-2022\/009"],"award-info":[{"award-number":["IN606B-2022\/009"]}],"id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","award":["IN607A 2020\/05"],"award-info":[{"award-number":["IN607A 2020\/05"]}],"id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.biopha.2024.117666","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T10:24:41Z","timestamp":1733135081000},"page":"117666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Activity and resistance mechanisms of the third generation tetracyclines tigecycline, eravacycline and omadacycline against nationwide Spanish collections of carbapenemase-producing Enterobacterales and Acinetobacter baumannii"],"prefix":"10.1016","volume":"181","author":[{"given":"Patricia","family":"Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8456-0085","authenticated-orcid":false,"given":"Paula","family":"Guijarro-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3351-2064","authenticated-orcid":false,"given":"Cristina","family":"Lasarte-Monterrubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1603-9762","authenticated-orcid":false,"given":"Andrea","family":"Muras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Alonso-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6737-0239","authenticated-orcid":false,"given":"Michelle","family":"Outeda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Maceiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Carmen","family":"Fern\u00e1ndez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5066-3020","authenticated-orcid":false,"given":"Arianna","family":"Rodr\u00edguez-Coello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Garc\u00eda-Pose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1636-6429","authenticated-orcid":false,"given":"Tania","family":"Blanco-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8387-3784","authenticated-orcid":false,"given":"Luc\u00eda","family":"Gonz\u00e1lez-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Arca-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"V\u00e1zquez-Ucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Bou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-7815","authenticated-orcid":false,"given":"Alejandro","family":"Beceiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117666_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.biopha.2024.117666_bib2","first-page":"240","article-title":"Tigecycline - how powerful is it in the fight against antibiotic-resistant bacteria?","volume":"46","author":"Seputiene","year":"2010","journal-title":"Med. (Kaunas. )"},{"key":"10.1016\/j.biopha.2024.117666_bib3","unstructured":"FDA. FDA Approved Drug Products, Tygacil. Full prescribing information. 2016. \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/021821s026s031lbl.pdf\u3009, n.d."},{"key":"10.1016\/j.biopha.2024.117666_bib4","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/cid\/cis270","article-title":"Excess deaths associated with tigecycline after approval based on noninferiority trials","volume":"54","author":"Prasad","year":"2012","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.biopha.2024.117666_bib5","first-page":"25","article-title":"Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs","volume":"39","author":"Shen","year":"2015","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"10.1016\/j.biopha.2024.117666_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/jam.13169","article-title":"Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methods","volume":"121","author":"Osei Sekyere","year":"2016","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.biopha.2024.117666_bib7","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2147\/IDR.S396910","article-title":"Antibacterial activity of eravacycline against carbapenem-resistant gram-negative isolates in China: an in vitro Study","volume":"16","author":"Zou","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.biopha.2024.117666_bib8","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s40262-019-00767-z","article-title":"Clinical pharmacokinetics and pharmacodynamics of eravacycline","volume":"58","author":"McCarthy","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.biopha.2024.117666_bib9","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s10096-019-03590-3","article-title":"Eravacycline, a newly approved fluorocycline","volume":"38","author":"Lee","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol."},{"key":"10.1016\/j.biopha.2024.117666_bib10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/1060028018818094","article-title":"Omadacycline: a new tetracycline antibiotic","volume":"53","author":"Dougherty","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.biopha.2024.117666_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa071","article-title":"Early experience with eravacycline for complicated infections","volume":"7","author":"Alosaimy","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.biopha.2024.117666_bib12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jgar.2021.02.009","article-title":"Efficacy and safety of eravacycline: a meta-analysis","volume":"24","author":"Eljaaly","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.biopha.2024.117666_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40265-020-01257-4","article-title":"Omadacycline: a novel oral and intravenous aminomethylcycline antibiotic agent","volume":"80","author":"Zhanel","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2024.117666_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.biopha.2024.117666_bib15","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1128\/AAC.01803-13","article-title":"Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance","volume":"58","author":"Villa","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib16","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/jac\/dkab079","article-title":"Prevalence of RND efflux pump regulator variants associated with tigecycline resistance in carbapenem-resistant Acinetobacter baumannii from a worldwide survey","volume":"76","author":"Luca\u00dfen","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib17","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/microorganisms9040730","article-title":"Present and future perspectives on therapeutic options for carbapenemase-producing enterobacterales infections","volume":"9","author":"Vrancianu","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.biopha.2024.117666_bib18","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/jac\/dkab043","article-title":"Activity of imipenem\/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales","volume":"76","author":"V\u00e1zquez-Ucha","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib19","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.02304-15","article-title":"What Is the appropriate meropenem MIC for screening of carbapenemase-producing Enterobacteriaceae in low-prevalence settings?","volume":"60","author":"Fattouh","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib20","article-title":"Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study","volume":"29","author":"Lasarte-Monterrubio","year":"2024","journal-title":"Eur. Surveill. Bull. Eur. Sur Les. Mal. Transm. = Eur. Commun. Dis. Bull."},{"key":"10.1016\/j.biopha.2024.117666_bib21","series-title":"CLSI document M100","article-title":"Performance Standards for Antimicrobial Susceptibility Testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2023"},{"key":"10.1016\/j.biopha.2024.117666_bib22","article-title":"Development of a novel streamlined workflow (AACRE) and database (inCREDBle) for genomic analysis of carbapenem-resistant Enterobacterales","volume":"9","author":"Alioto","year":"2023","journal-title":"Microb. Genom."},{"key":"10.1016\/j.biopha.2024.117666_bib23","unstructured":"T. Seemann, Abricate, (n.d.). \u3008https:\/\/github.com\/tseemann\/abricate\u3009."},{"key":"10.1016\/j.biopha.2024.117666_bib24","unstructured":"T. Seemann, Snippy: fast bacterial variant calling from NGS reads., (2015). \u3008https:\/\/github.com\/tseemann\/snippy\u3009."},{"key":"10.1016\/j.biopha.2024.117666_bib25","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1128\/AAC.00072-07","article-title":"Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate","volume":"51","author":"P\u00e9rez","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib26","article-title":"The plasmid-borne tet(A) gene is an important factor causing tigecycline resistance in ST11 carbapenem-resistant Klebsiella pneumoniae under selective pressure","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2024.117666_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jgar.2022.01.007","article-title":"Evolution of tet(A) variant mediating tigecycline resistance in KPC-2-producing Klebsiella pneumoniae during tigecycline treatment","volume":"28","author":"Liao","year":"2022","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.biopha.2024.117666_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11123000","article-title":"Tigecycline sensitivity reduction in Escherichia coli due to widely distributed tet(A) variants","volume":"11","author":"Zhang","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.biopha.2024.117666_bib29","article-title":"Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii","volume":"5","author":"Hamidian","year":"2019","journal-title":"Microb. Genom."},{"key":"10.1016\/j.biopha.2024.117666_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02759-21","article-title":"Carbapenem-resistant Acinetobacter baumannii in U.S. Hospitals: diversification of circulating lineages and antimicrobial Resistance","volume":"13","author":"Iovleva","year":"2022","journal-title":"MBio"},{"key":"10.1016\/j.biopha.2024.117666_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049534","article-title":"A truncated AdeS kinase protein generated by ISAba1 insertion correlates with tigecycline resistance in Acinetobacter baumannii","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.117666_bib32","doi-asserted-by":"crossref","DOI":"10.1590\/s1678-9946202062088","article-title":"Tetracycline resistance mediated by tet efflux pumps in clinical isolates of Acinetobacter baumannii","volume":"62","author":"Beheshti","year":"2020","journal-title":"Rev. Inst. Med. Trop. Sao Paulo."},{"key":"10.1016\/j.biopha.2024.117666_bib33","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/jac\/dkw002","article-title":"Single amino acid substitution Gly186Val in AdeS restores tigecycline susceptibility of Acinetobacter baumannii","volume":"71","author":"Sun","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib34","doi-asserted-by":"crossref","first-page":"i47","DOI":"10.1093\/jac\/dkaa497","article-title":"Role of new antibiotics for KPC-producing Klebsiella pneumoniae","volume":"76","author":"Theuretzbacher","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jgar.2023.04.017","article-title":"In vitro activity of eravacycline and comparators against Gram-negative and Gram-positive bacterial isolates collected from patients globally between 2017 and 2020","volume":"33","author":"Hawser","year":"2023","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.biopha.2024.117666_bib36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12866-020-02019-8","article-title":"Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study","volume":"20","author":"Xiao","year":"2020","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.biopha.2024.117666_bib37","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jmii.2022.09.009","article-title":"In vitro susceptibility of common Enterobacterales to eravacycline in Taiwan","volume":"56","author":"Huang","year":"2023","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.biopha.2024.117666_bib38","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12879-019-4093-1","article-title":"In vitro activities of Eravacycline against 336 isolates collected from 2012 to 2016 from 11 teaching hospitals in China","volume":"19","author":"Zhao","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.biopha.2024.117666_bib39","article-title":"In Vitro activity of eravacycline against gram-negative bacilli isolated in clinical laboratories worldwide from 2013 to 2017","volume":"64","author":"Morrissey","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib40","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1128\/AAC.00436-16","article-title":"In Vitro activity of eravacycline against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii","volume":"60","author":"Livermore","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib41","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/jac\/dkab141","article-title":"In vitro activity of imipenem\/relebactam, meropenem\/vaborbactam, ceftazidime\/avibactam, cefepime\/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan","volume":"76","author":"Kuo","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib42","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001592","article-title":"Comparative in vitro activities of omadacycline, eravacycline and tigecycline against non-ESBL-producing, ESBL-producing and carbapenem-resistant isolates of K. pneumoniae","volume":"71","author":"Mirza","year":"2022","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.biopha.2024.117666_bib43","first-page":"941","volume":"20","author":"Jean","year":"2022"},{"key":"10.1016\/j.biopha.2024.117666_bib44","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jmii.2021.08.012","article-title":"In vitro activity of cefiderocol, cefepime\/enmetazobactam, cefepime\/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloods","volume":"55","author":"Liu","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.biopha.2024.117666_bib45","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10096-023-04616-7","article-title":"In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020-2021: a multicenter study","volume":"42","author":"Galani","year":"2023","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol."},{"key":"10.1016\/j.biopha.2024.117666_bib46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jgar.2023.06.011","article-title":"Outbreak of high-risk XDR CRAB of international clone 2 (IC2) in Rio Janeiro, Brazil","volume":"34","author":"Morgado","year":"2023","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.biopha.2024.117666_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijantimicag.2011.09.016","article-title":"Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy","volume":"39","author":"Giannouli","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2024.117666_bib48","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/jac\/dkv420","article-title":"Tigecycline resistance in clinical isolates of Enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M)","volume":"71","author":"Fiedler","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/dku340","article-title":"Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae","volume":"70","author":"Bialek-Davenet","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib50","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1128\/AAC.00456-12","article-title":"Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae","volume":"56","author":"Veleba","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41426-018-0141-y","article-title":"Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae","volume":"7","author":"Zheng","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.biopha.2024.117666_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02930-19","article-title":"Emergence of a plasmid-encoded resistance-nodulation-division efflux pump conferring resistance to multiple drugs, including tigecycline, in Klebsiella pneumoniae","volume":"11","author":"Lv","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.biopha.2024.117666_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01326-19","article-title":"Novel Plasmid-Mediated tet(X5) Gene Conferring Resistance to Tigecycline, Eravacycline, and Omadacycline in a Clinical Acinetobacter baumannii Isolate","volume":"64","author":"Wang","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.584789","article-title":"AdeABC efflux pump controlled by AdeRS two component system conferring resistance to tigecycline, omadacycline and eravacycline in clinical carbapenem resistant Acinetobacter nosocomialis","volume":"11","author":"Lee","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2024.117666_bib55","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/AAC.01388-10","article-title":"Efflux-mediated antibiotic resistance in Acinetobacter spp","volume":"55","author":"Coyne","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib56","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10096-014-2272-y","article-title":"Tigecycline resistance in Acinetobacter baumannii mediated by frameshift mutation in plsC, encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase","volume":"34","author":"Li","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol."},{"key":"10.1016\/j.biopha.2024.117666_bib57","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s42003-022-03465-y","article-title":"Functional and phylogenetic analysis of TetX variants to design a new classification system","volume":"5","author":"Cheng","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.biopha.2024.117666_bib58","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/s41564-019-0445-2","article-title":"Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans","volume":"4","author":"He","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.biopha.2024.117666_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1141490","article-title":"Resistance mechanisms of tigecycline in Acinetobacter baumannii","volume":"13","author":"Sun","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biopha.2024.117666_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102476","article-title":"Proteolysis and multimerization regulate signaling along the two-component regulatory system AdeRS","volume":"24","author":"Ouyang","year":"2021","journal-title":"IScience"},{"key":"10.1016\/j.biopha.2024.117666_bib61","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1128\/AAC.02556-12","article-title":"RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations","volume":"57","author":"Yoon","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.117666_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00217-22","article-title":"Differential binding of carbapenems with the adeabc efflux pump and modulation of the expression of AdeB linked to novel mutations within two-component system AdeRS in carbapenem-resistant Acinetobacter baumannii","volume":"7","author":"Roy","year":"2022","journal-title":"MSystems"},{"key":"10.1016\/j.biopha.2024.117666_bib63","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s10096-014-2179-7","article-title":"AdeRS combination codes differentiate the response to efflux pump inhibitors in tigecycline-resistant isolates of extensively drug-resistant Acinetobacter baumannii","volume":"33","author":"Sun","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222401552X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222401552X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:02:19Z","timestamp":1787922139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222401552X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":63,"alternative-id":["S075333222401552X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117666","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity and resistance mechanisms of the third generation tetracyclines tigecycline, eravacycline and omadacycline against nationwide Spanish collections of carbapenemase-producing Enterobacterales and Acinetobacter baumannii","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117666"}}